14. Invites, in this context, the President of the General Assembly to make recommendations, for consideration by Member States during the preparatory process, for final decision by the Assembly as soon as possible, but not later than 2 March 2001, as to the form of the involvement of such civil society actors, in particular associations of people living with HIV/AIDS, non-governmental organizations and the business sector, including pharmaceutical companies, in the special session and, to the extent possible, in the preparatory process;